857230P
Avanti
C18:1 LPA
1-(9Z-octadecenyl)-2-hydroxy-sn-glycero-3-phosphate (ammonium salt), powder
Sign Into View Organizational & Contract Pricing
All Photos(2)
Synonym(s):
1-O-9-(Z)-octadecenyl-sn-glycero-3-phosphate (ammonium salt); PA(18:1(9Z)e/0:0)
Empirical Formula (Hill Notation):
C21H46NO6P
Recommended Products
Assay
>99% (LPA; may contain up to 10% of the 2-LPA isomer, TLC)
form
powder
packaging
pkg of 1 × 1 mg (857230P-1mg)
manufacturer/tradename
Avanti Polar Lipids 857230P
lipid type
cardiolipins
phospholipids
shipped in
dry ice
storage temp.
−20°C
SMILES string
O[C@](COP([O-])(O)=O)([H])COCCCCCCCC/C=C\CCCCCCCC.[NH4+]
General description
C18:1 LPA is a bioactive lipid. This lysophosphatidic acid (LPA), soluble lipid is obtained from membrane phospholipid. It is present in blood plasma.
Application
C18:1 LPA is suitable to stimulate human embryonic kidney 293 cells (HEK 293) cells in luciferase assay. It is also suitable to use as an additive in Dulbecco′s modified eagle medium (DMEM) for transwell migration assay, wound‐healing assay and cell proliferation assay.
Biochem/physiol Actions
Lysophosphatidic acid (LPA) signaling participates in various cellular processes. It is also associated with neurological disorders, inflammation and cancer.
Packaging
5 mL Clear Glass Sealed Ampule (857230P-1mg)
WGK
WGK 3
Flash Point(F)
No data available
Flash Point(C)
No data available
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Lysophosphatidic acid and its receptor LPA1 mediate carrageenan induced inflammatory pain in mice
Srikanth M, et al.
European Journal of Pharmacology, 841, 49- 56 (2018)
R D Moreno-Fernández et al.
Neuropharmacology, 164, 107896-107896 (2019-12-08)
The LPA1 receptor, one of the six characterized G protein-coupled receptors (LPA1-6) through which lysophosphatidic acid acts, is likely involved in promoting normal emotional behaviours. Current data suggest that the LPA-LPA1-receptor pathway may be involved in mediating the negative consequences
Autotaxin is a novel target of micro RNA-101-3p
Wang Y, et al.
FEBS Open Bio, 9(4), 707- 716 (2019)
Jesica R Williams et al.
The Journal of biological chemistry, 284(25), 17304-17319 (2009-04-16)
Lysophosphatidic acid (LPA) is a ligand for LPA(1-3) of the endothelial differentiation gene family G-protein-coupled receptors, and LPA(4-8) is related to the purinergic family G-protein-coupled receptor. Because the structure-activity relationship (SAR) of GPR92/LPA(5) is limited and whether LPA is its
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service